{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:52:22Z","timestamp":1789095142972,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"MJFF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009873","name":"Sardinia Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.nbd.2018.09.018","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T13:09:50Z","timestamp":1537794590000},"page":"120-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction"],"prefix":"10.1016","volume":"121","author":[{"given":"Silvia","family":"Fanni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0229-6090","authenticated-orcid":false,"given":"Simona","family":"Scheggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Tronci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Traccis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Stancampiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Graziella","family":"De Montis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Devoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Gambarana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bortolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Frau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manolo","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2018.09.018_bb0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.steroids.2009.10.005","article-title":"An overview on 5\u03b1-reductase inhibitors","volume":"75","author":"Aggarwal","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.nbd.2018.09.018_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.20296","article-title":"Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia","volume":"57","author":"Aubert","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2018.09.018_bb0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.07.002","article-title":"Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease","volume":"132","author":"Bastide","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2018.09.018_bb0020","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm875","article-title":"Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function","volume":"9","author":"B\u00e9zard","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2018.09.018_bb0025","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1046\/j.1460-9568.2000.00089.x","article-title":"Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats","volume":"12","author":"Bordet","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2018.09.018_bb0030","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1176\/appi.ajp.2007.07060978","article-title":"Treatment of Tourette's syndrome with finasteride","volume":"164","author":"Bortolato","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nbd.2018.09.018_bb0035","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1038\/npp.2008.39","article-title":"Antipsychotic-like properties of 5-alpha-reductase inhibitors","volume":"33","author":"Bortolato","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2018.09.018_bb0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/WNF.0b013e3181dca96f","article-title":"Treatment of benign essential blepharospasm with finasteride: a case report","volume":"33","author":"Bortolato","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.nbd.2018.09.018_bb0045","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/JCP.0b013e3182549c2a","article-title":"Finasteride attenuates pathological gambling in patients with Parkinson disease","volume":"32","author":"Bortolato","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.nbd.2018.09.018_bb0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0079-6123(10)83011-0","article-title":"Maladaptive striatal plasticity in L-DOPA-induced dyskinesia","volume":"183","author":"Cenci","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2018.09.018_bb0055","first-page":"25","article-title":"Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice","volume":"9","author":"Cenci","year":"2007","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.nbd.2018.09.018_bb0060","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.euroneuro.2013.05.012","article-title":"Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder","volume":"23","author":"Denys","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2018.09.018_bb0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1464-410X.2006.06241.x","article-title":"Effect of dutasteride on the symptoms of benign prostatic hyperplasia, and patient quality of life and discomfort, in clinical practice","volume":"98","author":"Desgrandchamps","year":"2006","journal-title":"BJU Int."},{"key":"10.1016\/j.nbd.2018.09.018_bb0070","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.psyneuen.2011.09.018","article-title":"Inhibition of 5\u03b1-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation","volume":"37","author":"Devoto","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.nbd.2018.09.018_bb0075","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.neuropharm.2006.10.015","article-title":"Neurosteroid dehydroepiandrosterone sulfate enhances spontaneous glutamate release in rat prelimbic cortex through activation of dopamine D1 and sigma-1 receptor","volume":"52","author":"Dong","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2018.09.018_bb0080","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1007\/s12035-014-8936-x","article-title":"Stronger dopamine D1 receptor-mediated neurotransmission in dyskinesia","volume":"52","author":"Farr\u00e9","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2018.09.018_bb0085","doi-asserted-by":"crossref","first-page":"12387","DOI":"10.1523\/JNEUROSCI.0150-11.2011","article-title":"Neurobiology of tourette syndrome: current status and need for further investigation","volume":"31","author":"Felling","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.09.018_bb0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fnbeh.2011.00071","article-title":"L-DOPA-induced dyskinesia and abnormal signaling in striatal medium spiny neurons: focus on dopamine D1 receptor-mediated transmission","volume":"5","author":"Feyder","year":"2011","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.nbd.2018.09.018_bb0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/mol.107.043885","article-title":"Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization","volume":"74","author":"Fiorentini","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2018.09.018_bb0100","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.euroneuro.2014.11.021","article-title":"The D3 dopamine receptor: from structural interactions to function","volume":"25","author":"Fiorentini","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2018.09.018_bb0105","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mds.26581","article-title":"Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease","volume":"31","author":"Fiorentini","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2018.09.018_bb0110","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.psyneuen.2012.07.014","article-title":"Inhibition of 5\u03b1-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL\/6 mice","volume":"38","author":"Frau","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.nbd.2018.09.018_bb0115","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.schres.2015.04.044","article-title":"Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress","volume":"168","author":"Frau","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.nbd.2018.09.018_bb0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.psyneuen.2015.09.014","article-title":"The neurosteroidogenic enzyme 5\u03b1-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating","volume":"63","author":"Frau","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.nbd.2018.09.018_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2017.01.012","article-title":"The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease","volume":"291","author":"Frau","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2018.09.018_bb0130","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbr.2009.09.028","article-title":"Infusions of anti-sense oligonucleotides for DARPP-32 to the ventral tegmental area reduce effects of progesterone- and a dopamine type 1-like receptor agonist to facilitate lordosis","volume":"206","author":"Frye","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2018.09.018_bb0135","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.psyneuen.2003.10.004","article-title":"5alpha-reduced androgens may have actions in the hippocampus to enhance cognitive performance of male rats","volume":"29","author":"Frye","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.nbd.2018.09.018_bb0140","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.pbb.2011.06.031","article-title":"Morphine sensitization as a model of mania: Comparative study of the effects of repeated lithium or carbamazepine administration","volume":"99","author":"Grappi","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2018.09.018_bb0145","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35075076","article-title":"BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization","volume":"411","author":"Guillin","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.09.018_bb0150","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/mol.114.093096","article-title":"Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer","volume":"86","author":"Guitart","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2018.09.018_bb0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0893-133X(01)00428-6","article-title":"The functional neuroanatomy of Tourette's syndrome: an FDG PET study III: functional coupling of regional cerebral metabolic rates","volume":"27","author":"Jeffries","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2018.09.018_bb0160","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jaad.2003.07.021","article-title":"A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris","volume":"50","author":"Leyden","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.nbd.2018.09.018_bb0165","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2018.09.018_bb0170","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.euroneuro.2005.10.002","article-title":"Dehydroepiandrosterone (DHEA) attenuates cocaine-seeking behavior in the self-administration model in rats","volume":"16","author":"Maayan","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2018.09.018_bb0175","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1126\/science.287.5455.1053","article-title":"Requirement for DARPP-32 in progesterone-facilitated sexual receptivity in female rats and mice","volume":"287","author":"Mani","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.nbd.2018.09.018_bb0180","doi-asserted-by":"crossref","first-page":"26016","DOI":"10.1074\/jbc.M710349200","article-title":"Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum","volume":"283","author":"Marcellino","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2018.09.018_bb0185","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1111\/bph.13232","article-title":"Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long-Evans rats","volume":"173","author":"Mosher","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2018.09.018_bb0190","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/mds.23810","article-title":"A preliminary study of finasteride in Tourette syndrome","volume":"26","author":"Muroni","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2018.09.018_bb0195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/138161211795049589","article-title":"Steroid 5\u03b1-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders","volume":"17","author":"Paba","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.nbd.2018.09.018_bb0200","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopsych.2005.05.044","article-title":"ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice","volume":"59","author":"Pav\u00f3n","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2018.09.018_bb0205","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.nbd.2018.09.018_bb0210","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2018.09.018_bb0215","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/sj.npp.1300885","article-title":"Sigma1 receptor ligands and related neuroactive steroids interfere with the cocaine-induced state of memory","volume":"31","author":"Romieu","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2018.09.018_bb0220","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1523\/JNEUROSCI.0852-07.2007","article-title":"Critical involvement of cAMP\/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia","volume":"27","author":"Santini","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.09.018_bb0225","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuroscience.2009.06.053","article-title":"Dopamine D1 receptor-dependent modifications in the dopamine and cAMP-regulated phosphoprotein of Mr 32 kDa phosphorylation pattern in striatal areas of morphine-sensitized rats","volume":"163","author":"Scheggi","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2018.09.018_bb0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuroscience.2017.03.056","article-title":"Fasting biases \u03bc-opioid receptors toward b-arrestin2-dependent signaling in the accumbens shell","volume":"352","author":"Scheggi","year":"2017","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.nbd.2018.09.018_bb0235","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00702-018-1852-x","article-title":"Dopamine receptors: homomeric and heteromeric complexes in L-DOPA-induced dyskinesia","volume":"125","author":"Sol\u00eds","year":"2018","journal-title":"J. Neural. Transm. (Vienna)"},{"key":"10.1016\/j.nbd.2018.09.018_bb0240","first-page":"435","article-title":"Dopamine D3 receptor modulates l-DOPA-induced dyskinesia by targeting D1 receptor-mediated striatal signaling","volume":"27","author":"Sol\u00eds","year":"2017","journal-title":"Cereb. Cortex."},{"issue":"8","key":"10.1016\/j.nbd.2018.09.018_bb0245","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00702-018-1847-7","article-title":"Signal transduction in L-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression","volume":"125","author":"Spigolon","year":"2018","journal-title":"J. Neural. Transm. (Vienna)"},{"key":"10.1016\/j.nbd.2018.09.018_bb0250","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.pharmtox.44.101802.121415","article-title":"DARPP-32: an integrator of neurotransmission","volume":"44","author":"Svenningsson","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.nbd.2018.09.018_bb0260","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nbd.2013.08.014","article-title":"5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson's disease model","volume":"60","author":"Tronci","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.09.018_bb0265","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuroscience.2014.01.042","article-title":"Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease","volume":"265","author":"Tronci","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2018.09.018_bb0270","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.1243985","article-title":"Pregnenolone can protect the brain from cannabis intoxication","volume":"343","author":"Vall\u00e9e","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.nbd.2018.09.018_bb0275","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1464-410X.2009.08743.x","article-title":"Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5alpha-reductase","volume":"104","author":"Vis","year":"2009","journal-title":"BJU Int."},{"key":"10.1016\/j.nbd.2018.09.018_bb0280","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.biopsych.2006.11.032","article-title":"Spatiotemporal pattern of striatal ERK1\/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors","volume":"62","author":"Westin","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2018.09.018_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051455","article-title":"Pregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout mice","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2018.09.018_bb0290","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.1038\/tp.2015.21","article-title":"Pregnenolone sulfate normalizes schizophrenia-like behaviors in dopamine transporter knockout mice through the AKT\/GSK3\u03b2 pathway","volume":"5","author":"Wong","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2018.09.018_bb0295","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1158\/1078-0432.CCR-06-0184","article-title":"Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers","volume":"12","author":"Xu","year":"2006","journal-title":"Clin. Cancer Res."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118306053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118306053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T14:39:59Z","timestamp":1565275199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996118306053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":58,"alternative-id":["S0969996118306053"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2018.09.018","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2018.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}